TO READ THIS STORY - you must have a paid subscription to Technology Review OR you can purchase special archive reading credits here. Choose from these great offers below.

I'm a paid subscriber please
log me in

I want to purchase this article for
only 99¢
(requires login)

I want to purchase five articles for
only $3.99
(requires login)

I want to buy
1 Year TOTAL Access for
only $24.95
(requires login)

Please note: Click here if you are currently a Technology Review print or digital subscriber and do not have access to this article.

Click here if you are an MIT alum and do not have access to this article.

November/December 2008

Hard Road for Medical Treatments

Promising studies are often refuted later.

By Emily Singer

Only a tiny fraction of the compounds tested for different diseases ever make it to clinical trials. Now a report in Science suggests that the results of even encouraging clinical trials are later refuted with surprising frequency.

Select from the choices above
to read the entire article.

Customer Service

Magazine Services

•	Subscription FAQ
•	Pay Your Bill
•	Renew Your Subscription
•	Change Your Address
•	Check Your Start/Expire Issue
•	Feedback
•	Buy a Back Issue
•	Permissions/Reprints
•	Cancel Your Subscription
•	Digital Subscription Customer Service